Cargando…
Gelling hypotonic polymer solution for extended topical drug delivery to the eye
Eye-drop formulations should hold as high a concentration of soluble drug in contact with ocular epithelium for as long as possible. However, eye tears and frequent blinking limit drug retention on the ocular surface, and gelling drops typically form clumps that blur vision. Here, we describe a gell...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655548/ https://www.ncbi.nlm.nih.gov/pubmed/32895514 http://dx.doi.org/10.1038/s41551-020-00606-8 |
_version_ | 1783608222552162304 |
---|---|
author | Kim, Yoo Chun Shin, Matthew Hackett, Sean Hsueh, Henry T. e Silva, Raquel Lima Date, Abhijit Han, Hyounkoo Kim, Byung-Jin Xiao, Amy Kim, Youngwook Ogunnaike, Laolu Anders, Nicole M. Hemingway, Avelina He, Ping Jun, Albert S. McDonnell, Peter J. Eberhart, Charles Pitha, Ian Zack, Donald J. Campochiaro, Peter Hanes, Justin Ensign, Laura M. |
author_facet | Kim, Yoo Chun Shin, Matthew Hackett, Sean Hsueh, Henry T. e Silva, Raquel Lima Date, Abhijit Han, Hyounkoo Kim, Byung-Jin Xiao, Amy Kim, Youngwook Ogunnaike, Laolu Anders, Nicole M. Hemingway, Avelina He, Ping Jun, Albert S. McDonnell, Peter J. Eberhart, Charles Pitha, Ian Zack, Donald J. Campochiaro, Peter Hanes, Justin Ensign, Laura M. |
author_sort | Kim, Yoo Chun |
collection | PubMed |
description | Eye-drop formulations should hold as high a concentration of soluble drug in contact with ocular epithelium for as long as possible. However, eye tears and frequent blinking limit drug retention on the ocular surface, and gelling drops typically form clumps that blur vision. Here, we describe a gelling hypotonic solution containing a low concentration of a thermosensitive triblock copolymer, for extended ocular drug delivery. On topical application, the hypotonic formulation forms a highly uniform and clear thin layer that conforms to the ocular surface and resists clearance from blinking, significantly increasing the intraocular absorption of hydrophilic and hydrophobic drugs and extending the drug–ocular-epithelium contact time with respect to conventional thermosensitive gelling formulations and commercial eye drops. We also show that the conformal gel layer allows for therapeutically relevant drug delivery to the eyeball’s posterior segment in pigs. Our findings highlight the importance of formulations that conform to the ocular surface prior to viscosity enhancement, for increased and prolonged ocular-surface contact and drug absorption. |
format | Online Article Text |
id | pubmed-7655548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
record_format | MEDLINE/PubMed |
spelling | pubmed-76555482021-03-07 Gelling hypotonic polymer solution for extended topical drug delivery to the eye Kim, Yoo Chun Shin, Matthew Hackett, Sean Hsueh, Henry T. e Silva, Raquel Lima Date, Abhijit Han, Hyounkoo Kim, Byung-Jin Xiao, Amy Kim, Youngwook Ogunnaike, Laolu Anders, Nicole M. Hemingway, Avelina He, Ping Jun, Albert S. McDonnell, Peter J. Eberhart, Charles Pitha, Ian Zack, Donald J. Campochiaro, Peter Hanes, Justin Ensign, Laura M. Nat Biomed Eng Article Eye-drop formulations should hold as high a concentration of soluble drug in contact with ocular epithelium for as long as possible. However, eye tears and frequent blinking limit drug retention on the ocular surface, and gelling drops typically form clumps that blur vision. Here, we describe a gelling hypotonic solution containing a low concentration of a thermosensitive triblock copolymer, for extended ocular drug delivery. On topical application, the hypotonic formulation forms a highly uniform and clear thin layer that conforms to the ocular surface and resists clearance from blinking, significantly increasing the intraocular absorption of hydrophilic and hydrophobic drugs and extending the drug–ocular-epithelium contact time with respect to conventional thermosensitive gelling formulations and commercial eye drops. We also show that the conformal gel layer allows for therapeutically relevant drug delivery to the eyeball’s posterior segment in pigs. Our findings highlight the importance of formulations that conform to the ocular surface prior to viscosity enhancement, for increased and prolonged ocular-surface contact and drug absorption. 2020-09-07 2020-11 /pmc/articles/PMC7655548/ /pubmed/32895514 http://dx.doi.org/10.1038/s41551-020-00606-8 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms Reprints and permissions information is available at www.nature.com/reprints (http://www.nature.com/reprints) . |
spellingShingle | Article Kim, Yoo Chun Shin, Matthew Hackett, Sean Hsueh, Henry T. e Silva, Raquel Lima Date, Abhijit Han, Hyounkoo Kim, Byung-Jin Xiao, Amy Kim, Youngwook Ogunnaike, Laolu Anders, Nicole M. Hemingway, Avelina He, Ping Jun, Albert S. McDonnell, Peter J. Eberhart, Charles Pitha, Ian Zack, Donald J. Campochiaro, Peter Hanes, Justin Ensign, Laura M. Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title | Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title_full | Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title_fullStr | Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title_full_unstemmed | Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title_short | Gelling hypotonic polymer solution for extended topical drug delivery to the eye |
title_sort | gelling hypotonic polymer solution for extended topical drug delivery to the eye |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655548/ https://www.ncbi.nlm.nih.gov/pubmed/32895514 http://dx.doi.org/10.1038/s41551-020-00606-8 |
work_keys_str_mv | AT kimyoochun gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT shinmatthew gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT hackettsean gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT hsuehhenryt gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT esilvaraquellima gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT dateabhijit gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT hanhyounkoo gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT kimbyungjin gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT xiaoamy gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT kimyoungwook gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT ogunnaikelaolu gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT andersnicolem gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT hemingwayavelina gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT heping gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT junalberts gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT mcdonnellpeterj gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT eberhartcharles gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT pithaian gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT zackdonaldj gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT campochiaropeter gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT hanesjustin gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye AT ensignlauram gellinghypotonicpolymersolutionforextendedtopicaldrugdeliverytotheeye |